Loading...
| Name | Option type | Quality (1-5)↓ | Topics | Created | |
|---|---|---|---|---|---|
Number of additional FDA approvals for Geron by end of 2024  | Categorical | 5 | 7 months ago | ||
Number of new clinical trials published for Rytelo by end of 2024 | Categorical | 5 | 7 months ago | ||
Geron stock closes above $10 by July 7, 2024? | Binary | 5 | 7 months ago | ||
Rytelo approved by EMA by end of 2024? | Binary | 5 | 7 months ago | ||
Geron stock price range at end of Q3 2024 | Categorical | 5 | 7 months ago | ||
Will Rytelo sales exceed $100 million by end of 2024?  | Binary | 5 | 7 months ago | ||
Will Geron's stock price stay above $3.50 by end of Q3 2024? | Binary | 5 | 7 months ago | ||
What will be Geron's next major milestone by end of 2024? | Categorical | 5 | 7 months ago | ||
What will Geron's market cap be by end of 2024? | Categorical | 5 | 7 months ago | ||
What will be Rytelo's market penetration in MDS treatment by end of 2024? | Categorical | 5 | 7 months ago | ||
Rytelo sales exceed $50 million in Q3 2024? | Binary | 4 | 7 months ago | ||
Will Rytelo receive EMA approval by mid-2025? | Binary | 3 | 7 months ago |